Clinical Decision Support System with Renal Dose Adjustment Did Not Improve Subsequent Renal and Hepatic Function among Inpatients: The Japan Adverse Drug Event Study.

Ryuhei WadaJiro TakeuchiTsukasa NakamuraTomohiro SonoyamaShinji KosakaChisa MatsumotoMio SakumaYoshinori OhtaTakeshi Morimoto

Published in: Applied clinical informatics (2020)

The CDSS implementation did not affect the incidence of renal and HD and changes in renal and hepatic function among hospitalized patients. The effectiveness of the CDSS with renal-guided doses should be investigated with respect to other endpoints.

Keyphrases

clinical decision support
adverse drug
healthcare
randomized controlled trial
systematic review
primary care
emergency department
risk factors
high resolution
quality improvement
drug induced